Literature DB >> 30355104

Persistently Elevated Microvascular Resistance Postrecanalization.

Felix C Ng1, Bronwyn Coulton1, Brian Chambers1,2, Vincent Thijs1,3.   

Abstract

Background and Purpose- Impaired microvascular reperfusion despite complete recanalization (no-reflow) represents a potential therapeutic target to improve outcomes after recanalization therapies. Although well documented in animal models, this phenomenon has not been demonstrated clinically. We investigated whether transcranial Doppler can detect acute microvascular changes postrecanalization as a biomarker of the no-reflow phenomenon in stroke patients. Methods- Consecutive patients with recanalized (Thrombolysis in Cerebral Infarction grade IIb/III) acute middle cerebral artery occlusion by thrombectomy at a Comprehensive Stroke Centre with a high-volume neurovascular laboratory were retrospectively identified. Sonographic measures of middle cerebral artery territory microvascular resistance (pulsatility index and resistive index) on days 1 to 3 follow-up transcranial Doppler were compared between patients and age/gender-matched controls. Results- In 53 patients, middle cerebral artery pulsatility index was significantly more likely to be asymmetrically increased on interside comparison (27.9% versus 4.9%; P=0.007) and abnormally elevated beyond normal reference ranges (46.7% versus 22.0%; P=0.016) in the symptomatic hemisphere. Middle cerebral artery pulsatility index elevation was associated with less hemorrhagic infarction (9.5% versus 45.8%; P=0.009) but worse functional outcome irrespective of infarct volume as assessed on 90-day modified Rankin Scale (score of ≤1, 18.2% versus 58.1%; P=0.035). Conclusions- Elevated microvascular resistance within the ischemic territory is commonly present after successful recanalization as measured by pulsatility index on transcranial Doppler and may be a readily available and clinically relevant biomarker of the no-reflow phenomenon.

Entities:  

Keywords:  biomarker; cerebral infarction; infarction; reperfusion injury; thrombectomy

Mesh:

Substances:

Year:  2018        PMID: 30355104     DOI: 10.1161/STROKEAHA.118.021631

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  5 in total

Review 1.  Imaging After Thrombolysis and Thrombectomy: Rationale, Modalities and Management Implications.

Authors:  Felix C Ng; Bruce C V Campbell
Journal:  Curr Neurol Neurosci Rep       Date:  2019-07-06       Impact factor: 5.081

Review 2.  Management of Blood Pressure During and After Recanalization Therapy for Acute Ischemic Stroke.

Authors:  Jeffrey R Vitt; Michael Trillanes; J Claude Hemphill
Journal:  Front Neurol       Date:  2019-02-21       Impact factor: 4.003

3.  Macrophage-Disguised Manganese Dioxide Nanoparticles for Neuroprotection by Reducing Oxidative Stress and Modulating Inflammatory Microenvironment in Acute Ischemic Stroke.

Authors:  Chao Li; Zhenhao Zhao; Yifan Luo; Tingting Ning; Peixin Liu; Qinjun Chen; Yongchao Chu; Qin Guo; Yiwen Zhang; Wenxi Zhou; Hongyi Chen; Zheng Zhou; Yu Wang; Boyu Su; Haoyu You; Tongyu Zhang; Xuwen Li; Haolin Song; Chufeng Li; Tao Sun; Chen Jiang
Journal:  Adv Sci (Weinh)       Date:  2021-08-26       Impact factor: 16.806

4.  Efficacy of Cerebrolysin Treatment as an Add-On Therapy to Mechanical Thrombectomy in Patients With Acute Ischemic Stroke Due to Large Vessel Occlusion: Study Protocol for a Prospective, Open Label, Single-Center Study With 12 Months of Follow-Up.

Authors:  Jacek Staszewski; Adam Stȩpień; Renata Piusińska-Macoch; Aleksander Dȩbiec; Katarzyna Gniadek-Olejniczak; Emilia Frankowska; Artur Maliborski; Zoltan Chadaide; David Balo; Beata Król; Rafael Namias; George Harston; Józef Mróz; Piotr Piasecki
Journal:  Front Neurol       Date:  2022-07-04       Impact factor: 4.086

5.  Elevated pulsatility index is associated with poor functional outcome in stroke patients treated with thrombectomy: A retrospective cohort study.

Authors:  Wenbo Zhao; Ran Liu; Wantong Yu; Longfei Wu; Chuanjie Wu; Chuanhui Li; Sijie Li; Jian Chen; Haiqing Song; Yang Hua; Qingfeng Ma; Xunming Ji
Journal:  CNS Neurosci Ther       Date:  2022-06-16       Impact factor: 7.035

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.